Amelioration of diabetic nephropathy in mice by a single intravenous injection of human mesenchymal stromal cells at early and later disease stages is associated with restoration of autophagy.
Jingjing HeBoxin LiuXiaofeng DuYan WeiDesheng KongBaofeng FengRuiyun GuoErnest Amponsah AsiamahMatthew D GriffinSean O HynesSanbing ShenYan LiuHuixian CuiJun MaTimothy O'BrienPublished in: Stem cell research & therapy (2024)
Single intravenous injections of hUC-MSCs ameliorated glomerular abnormalities and interstitial fibrosis in a mouse model of STZ-induced diabetes without affecting hyperglycemia, whether administered at relatively short or longer duration of diabetes. At both time-points, the reno-protective effects of hUC-MSCs were associated with reduced circulating TGF-β1 and restoration of intra-renal autophagy.
Keyphrases
- diabetic nephropathy
- diabetic rats
- oxidative stress
- type diabetes
- mouse model
- high glucose
- endothelial cells
- mesenchymal stem cells
- cell death
- cardiovascular disease
- endoplasmic reticulum stress
- glycemic control
- high dose
- signaling pathway
- umbilical cord
- ultrasound guided
- bone marrow
- transforming growth factor
- induced pluripotent stem cells
- high fat diet induced
- low dose
- drug induced
- pluripotent stem cells
- metabolic syndrome
- epithelial mesenchymal transition